Development and Testing of Nutritional Algorithms (NACHO)
Launched by DANA-FARBER CANCER INSTITUTE · Apr 21, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The NACHO study is looking at how to improve nutrition and overall well-being for people who are finishing or have completed cancer treatment. The researchers are developing a special program called the Nutrition Algorithm for Cancer Health Outcomes (NACHO), which uses technology to help patients get the right nutrition tailored to their needs. This study aims to find ways to help cancer survivors feel better and healthier after their treatment.
To be eligible for this study, participants need to be at least 18 years old and able to speak and read English. They should be either currently receiving cancer treatment or have completed their primary treatment. Participants will need access to a device like a computer or smartphone to use the program. The study is not yet recruiting participants, but it will involve collaboration with dietitians and oncology experts who have experience working with patients facing nutritional challenges. Overall, this research aims to create a supportive tool that can make a real difference in the lives of cancer survivors by focusing on their nutritional needs.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria for Dietitians/Oncology clinicians - Have worked with at least 3 patients at the study site who had nutritional challenges
- • Inclusion Criteria for Patient and Family Advisory Council (PFAC) participants
- • Current member of adult PFAC
- • \> 18 years old
- • Inclusion Criteria for Patient participants
- • \> 18 years old
- • Able to speak and read English
- • Completed primary treatment (aim 2b) or actively undergoing treatment (aim 2b and aim 3, exploratory)
- • Access to a device (e.g., computer, tablet, smartphone) through which they can receive and engage with a REDCap link
- • Exclusion Criteria for Patient Participants
- • • Provider does not recommend
About Dana Farber Cancer Institute
The Dana-Farber Cancer Institute is a premier cancer research and treatment institution located in Boston, Massachusetts. Renowned for its commitment to advancing cancer care through innovative research, the institute integrates cutting-edge clinical trials with a multidisciplinary approach to patient care. With a focus on translating scientific discoveries into effective therapies, Dana-Farber collaborates with a network of leading researchers and healthcare professionals to improve outcomes for patients with cancer. The institute’s dedication to education, advocacy, and community engagement further underscores its mission to eradicate cancer and enhance the quality of life for those affected by the disease.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Trial Officials
Marilyn Hammer, MD
Principal Investigator
Dana-Farber Cancer Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported